Nilotinib Hydrochloride Dihydrate is a potent tyrosine kinase inhibitor primarily used in the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. As a second-generation BCR-ABL inhibitor,… Read more
Nilotinib Hydrochloride Dihydrate is a potent tyrosine kinase inhibitor primarily used in the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. As a second-generation BCR-ABL inhibitor, it functions by targeting specific signaling pathways to disrupt malignant cell growth and proliferation. Within this category, you will find high-quality reference standards, including the active pharmaceutical ingredient, alongside a comprehensive range of impurities, metabolites, and stable isotope labelled compounds. These materials are essential for pharmaceutical laboratories conducting rigorous analytical testing, method validation, and quality control. By utilizing these precisely characterized compounds, researchers can perform accurate impurity profiling and quantitative analysis in various matrices. Whether supporting stability studies, regulatory submissions, or routine pharmaceutical characterization, these reference materials ensure the consistency and reliability required for the development and assessment of this therapeutic agent.